ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01859026
Brief Title: A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR Mutation

First Submitted : May 17, 2013
First Submitted that Met QC Criteria : May 17, 2013
First Posted : May 21, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : May 11, 2018
Last Update Posted : May 14, 2018